patients with childhood onset cyclic neutropenia demonstrated tinctly elevated levels. Cyclic neutropenia occurs both as a abnormal in vitro proliferative responses to purified, recombichildhood onset and an adult onset disease (I. 2). The latter nant human granulocyte-macrophage colony-stimulating factor form of the disease has been shown to respond to low-dose. (rhGM-CSF) when examined in detailed dose-response studalternate-day cortico-steroid therapy (2, 3) and has been assoies. Marrow aspirate specimens were obtained for these studciated with a "benign" lymphoproliferative neoplasm of large ies from cyclic neutropenia patients (both during neutropenic granular lymphocytes (2) . Childhood onset cyclic neutropenia, nadirs and during recovery phases of cycles), from leukemia on the other hand, appears to be congenital in most cases, is patients in remission who had received myelosuppressive chenot associated with a lymphoproliferative disorder, and commotherapy, and from healthy normal volunteers. Nucleated monly occurs in a familial pattern suggestive of an autosomal marrow cells were then isolated by density-gradient centrifugadominant mode of inheritance (0. 2). tion and cryopreserved to permit oetudie-of CFI i-GM from Studies of neuiophil kinetics in both adtilt and childhood patients and controls to be carried out at the same time and in onset cyclic neutropenia have shown that the oscillations of replicate. Maximum clonal growth of CFU-GM from normal blood neutrophil counts result from abnormalities in the regusubjects and from individuals recovering from drug-induced lation of neutrophil production and not from intermittent demyelosuppression was elicited by 20-100 pmol/liter rhGMstruction or an abnormal utilization of these cells (I, 4). Al-CSF, and the CSF concentrations that induced half-maximal though studies of hematopoietic progenitors in human cyclic responses (ED50) were between 1.0 and 3.0 pmol/liter. In conneutropenia have been limited, this disease does not appear to trast, maximum growth of CFU-GM from the cyclic neutrobe associated with reduced numbers of myeloid colony-formpenia patients required > 1.0 nmol/liter rhGM-CSF and ing cells (CFU-GM).' Rather, CFU-GM concentrations in the EDw's were > 30.0 pmol/liter. These abnormalities in the marrow have been reported to fluctuate between normal and GM-CSF responsive growth of myeloid progenitors were indeabove normal levels with peak levels coinciding with nadirs of pendent of cycle time and were most apparent with the predomneutropenia (5-8). inantly neutrophilic 7-d CFU-GM. Moreover, differences in Several mathematical models of the regulation of myelothe growth of 14-d CFU-GM could be attributed mostly if not poiesis have been based upon the distinctive features of cyclic entirely to differences in the generation of neutrophilic coloneutropenia (9-12). These models have predicted that myelonies. 'I hese findings indicate that childhood onset cyclic neupoisis should be intrinsically susceptible to oscillations if the tropenia is associated with an underlying disturbance in the proliferation and maturation of myeloid progenitor cells is GM-CSF responsive growth of myeloid progenitors committed regulated by a balance of positive and negative signals, involvto neutrophilic differentiation. ing a feedback loop in which regulatory signals are controlled in part by the mature cells (e.g. neutrophils and macrophages) Introduction that are generated. Futhermore, these models have provided a basis for the hypothesis that an abnormality in the responsiveHuman cyclic neutropenia (or "cyclic hematopoiesis") is a ness of progenitor cells to competing regulatory signals could rare but very distinctive disorder characterized by regular provoke cycling (12). oscillations in blood neutrophil and monocyte counts (I).
Recently, it has become possible to test this hypothesis by Neutrophil counts fall to profoundly low levels at regular 3-wk studying the clonal proliferation of myeloid progenitor cells in intervals, followed by a recovery phase during which neutroresponse to purified myelopoietic growth factors. Not only is there now substantial evidence that both positive and negative myelopoietic regulatory factors exist (13- GM in methylcellulose culture assays (ED,'s) and their variances were 37) with well-documented childhood onset cyclic neutropenia, from calculated using a computer-assisted analytic approach based upon a two male patients with acute leukemia in hematologic remission (ages modification of standard methods of probit analysis for quantal re-24 and 5 1) who had received high-dose myelosuppressive chemothersponse data, described by Finney (22). apy in post remission induction intensification protocols, and from eight healthy normal volunteers (ages 19-43) after informed consent in
Results
accordance with a protocol approved by the Clinical Investigation Committee of the Walter Reed Army Medical Center. All patients with
Rt'tivrt i/(I-'-G fron the ,arrow of patihnts with ''clw cyclic neutropenia had been followed clinica'ly (by D. Wright) for 6-12 yr and were known to have maintained consistent neutrophil cycles netropenia. None of the patients with childhood onset cyclic with stable cycle lengths and amplitudes: three of these patients have neutropenia were found to be deficient in myeloid progenitors.
been described previously (reference 1. patients 1, 5, and 8). Marrow Rather, concentrations of CFU-GM in the marrow of these aspirates from these patients were timed to coincide both with the individuals were generally higher than normal, and the highest 5-7-d periods during cycles when neutrophil counts were lowest levels were found to coincide with nadirs of neutropenia dur-("nadir") and with days when counts were highest ("recovery"'). Maring cycles. These findings, illustrated in Fig. 1 . are consistent row specimens from the patients who had received myelosuppressive with prior reports (5) (6) (7) (8) . Data shown in this figure were obchemotherapy were obtained 10-15 d after nadirs of drug induced tained from CFU-GM assays in which cryopreserved marrow neutropenia. as neutrophils were returning to the peripheral blood, cells were cultured with 1.0 nmol/liter rhGM-CSF, a concenSeparation and crvopreserration ofhone marrow cells. Individual tration of growth factor that was assumed to be well in excess marrow specimens of 8-15 ml were withdrawn from the posterior iliac o o that was assumd to be w in e crest into syringes containing preservative-iree heparin (100 U/ml, of that required for maximum mveloid colony growth based Gibeo Laboratories. Grand Island, NY) and then diluted 1:12 (vol/vol) upon the observations of others (19). Results similar to those in calcium-and magnesium-free Dulbecco's PBS. Light-density marshown in Fig. I were also obtained from CFU-GM assays of row cells (d < 1.075) were then isolated by centrifugation on Percoll light-density, adherence-depleted marrow cells that had not (Pharmacia Fine Chemicals, Uppsala. Sweden) gradients and were been cryopreserved: note. however, that these marrow cell either studied directly in CFU-GM assays (see below) or were cryoprepreparations were in all cases somewhat less enriched for served in 90% fetal bovine serum (FBS: Hyclone Sterile Systems, CFU-GM (by a factor of 1.3-1.5) when compared with cryoLogan. UT) and 10% DMSO as described previously (17). in multiple preserved cells prepared from the same marrow aspirate specialiquots (5 x 107 cells/aliquot) such that replicate studies could be carried out with each marrow cell isolate. 2 -2-nonadherent, light density-nucleated marrow cells that were recovered 5,A 3 after density centrifugation, cryopreservation, thawing, and adherence a depletion and were viable by due exclusion was routinely between 0.5 . and 1.0 x 10' cells per ml of marrow aspirate originally drawn. These recoveries were the same for both normal volunteer and patient speci--mens. The purified rhGM-CSF used in these cultures was generously NORMAL Cyclic NORMAL CYCLIC supplied to us by Dr. Gordon Wong of Genetics Institute, Cambridge.
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MA: its preparation has been described (18, 19) . This rhGM-CSF F/,ure 1. Concentrations of mycloid progenitors (CFU-GM) in crvopreparation was >97%, pure and had a specific activity of 4.7 preserved marrow cell isolates. Each point represents a mean value x 10' U/mg.
derived from a minimum of three replicate studies with separate aliMycloid (CFU-GM) colonies were counted with an inverned-phase quots of eight individual marrow specimens obtained from eight normicroscope at a magnification of 40 at both 7 and 14 d of culture using mal volunteers and six marrow specimens from four patients with standard scoring criteria (17, 20, 21). Neutrophil, macrophage. and cyclic neutropenia. Marrow specimens were obtained twice from two mixed neutrophil-macrophage colonies were also distinguished by cyclic neutropenic patients. once during the nadir (halfshaded st'mclonal morphology and were counted separately. To verify the identity bols) and once during the recovery phase of cycles ( vpen symbols): of colony types, individual colonies were plucked from the semi solid specimens were obtained from the other two patients either during a methylcellulose media of culture dishes, and the recovered cells were cycle nadir or during a recovery phase.
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men. The CFU-GM enrichment eflect ofcryopreservation was A equivalent for marrow cells from both patients and normal 7 DAY CFU-GM controls, as were the recoveries of viable nucleated cells relative to the numbers of these cells in the original marrow aspi-V80 AA rate specimens, after all isolation and cropreservation proce-W dures.
Under the culture conditions illustrated in Fig. I, CFUJ- 
60.
GM of cyclic neutropenia patients and normal controls were -indistinguishable both with respect to the relative numbers of 40 neutrophil colonies (45-60%). macrophage colonies (35-507), n and mixed neutrophil-macrophage colonies (3-12';' that de-. ing. As has been described by others (20, 21). neutrophilic colonies consisted of relatively small cells arrayed in a spread B pattern around a variously cellular and compact center.
14 DAY CJ-GM whereas macrophage colonies, which consisted of relatively large, pleomorphic cells, were somewhat less cellular and less 801, diffuse than neutrophilic colonies. Colonies that proved to be _3 eosinophilic were also detected occasionally (< 5% of total col-, onies) among CFU-GM grown with > 1.0 nmol/liter rhGM-CSF. Whereas the clonal morphology of these colonies was o somewhat similar to that of neutrophilic colonies. cosinophilic = 40 colonies were generally less cellular and more compact than , -neutrophilic colonies, and they consisted of cells that were , g more refractile when examined by phase microscopy. These t 0 . myelosuppression. The open and half-shaded symbols represent recent of maximum colony growth observed with individual suits for six marrow specimens from patients with cyclic neutromarrow cell isolates obtained from the four cyclic neutropenia penia, obtained during the recovery phase or nadir of cycles. respecpatients, from two patients recovering from chemotherapy-inlively: ---. mean values fbr the growth of CFtJ-GM from these paduced myelosuppression, and from eight normal volt......ers tients. whereas results of normal volunteer marrow studies have been combined to show mean values ±2 SD (95"; confidence limits), all data from the studies of marrow isolates from paseparate studies. In contrast, the rhGM-CSF responsive growth tients are shown separately, of r -, progenitor cells from patients recovering from As has been reported by others (19). maximum growth of druL-"ult.,',t myelosuppression was not different from nor-CFU-GM from normal individuals was elicited by 20-100 mal. ,." -cell isolates from these individuals were enriched pmol/liter rhGM-CSF. However, the dose responses for in CFU-,s4 (420-540 CFU-GM [14 dj/10 5 ervopreserved growth of CFU-GM from cyclic neutropenia marrow samples marrow cells) and were derived from marrow aspirate speciwere uniformly shifted to the right. parliculrly for the 7-d mens that histologically showed a substantial increase in rela-CFU-GM. and -1.0 nmol/litti rhGM-CSF was required to tive numbers of immature neutrophilic forms (promyelocytes elicit maximal clonal proliferation of these progenitors. These and myelocytes). like the marrow specimens of cyclic neutrodifferences in the rhGM-CSF responsive growth of CFU-GM penia patients during and immediately after neutropenic were equally apparent with marrow cells obtained during nadirs. nadirs and reLover. phases of cycles and with various cell Because differences in rhGM-CSF responses were most applating concentrations in the clonal assays. Results shown in parent with the predominantly neutrophilic (> 80%) 7 day markedly impaired in cyclic neutropenia, monocyte production is typically maintained at normal to increased levels.
Our findings are consistent with the conclusion that childvalues for the concentrations of rhGM-CSF (ED 50 ) that stimuhood onset cyclic neutropenia is associated with an intrinsic lated half-maximal growth of CFU-GM. These values were disturbance in the responsiveness of myeloid progenitor cells calculated from computer-fitted curves applied to dose-reto GM-CSF. This conclusion is of particular interest in that sponse data derived from replicate studies. As could be anticimathematical models of the regulation of myelopoiesis. based pated from the data shown in Fig. 2 . the mean ED 50 of rhGMupon the distinctive characteristics of cyclic neutropenia, have CSF required for growth of 7-d CFU-GM from cyclic neutropredicted that an abnormality in the responsiveness of propenia patients was substantially higher than that observed with genitor cells to regulatory signals could produce the oscillamarrow cells from normal volunteers. ED 50 's required for tions in blood cell production that are observed in this disease growth of 14-d CFU-GM were also significantly higher than (12) . However, our findings must be interpreted with caution normal, although absolute differences were less. However, in this regard. when 14-d neutrophilic and macrophage colonies were anaAlthough varying concentrations of pure. rhGM-CSF conlyzed separately, it was evident not only that maximal and stituted the sole experimental variable in progenitor cell assays half-maximal growth of macrophage colonies required less (other than the source of progenitor cells), it is unlikely that the GM-CSF than that required for growth of neutrophilic coloexpression of myeloid colony growth depended only upon the nies. as has been reported by others (21), but also that the presence of this growth factor in the in vitro culture system aberrant rhGM-CSF responsive growth of CFU-GM from cythat was used. There is compelling evidence from recent studclic neutropenia patients reflected primarily, if not entirely, an ies that clonal proliferation and differentiation of hcmatopoiabnormality in the growth of neutrophilic colonies.
etic progenitor cells are modulated by and may require the Results shown in Fig. 2 and Table I are from studies of cooperation of multiple humoral signals (21, 23-26). Hence, cryopreserved marrow cell isolates, each of which was examabnormalities in the in vitro growth of myeloid progenitor cells ined repeatedly. However, the abnormalities of GM-CSF refrom cyclic neutropenia patients could reflect a disturbance in sponsive growth of myeloid progenitors from cyclic neutrothe responsiveness of progenitor cells to a separate, cooperapenia patients that are shown were equally apparent in sepative signal provided by the FBS present in culture media or rate studies of noncryopreserved marrow cell isolates. In a generated by residual accessory cells in marrow cell isolates. representative study, in which cryopreserved and noncryopreIndeed, the lineage-restricted character of the abnormalities in served cells from the same marrow aspirate specimens were rhGM-CSF responsi'e progenitor cell growth that were obstudied in parallel, the ED 50 's of rhGM-CSF for stimulating served suggests that a separate regulatory factor more specific 7-d CFU-GM growth were found to be 2.48 and 2.61 pmol/ to the neutrophilic lineage (such as G-CSF) might also be inliter, respectively, for cryopreserved and noncryopreserved volved. cells from an individual normal donor marrow aspirate speciAdditional studies with more highly purified preparations men, vs. 24.9 and 18.3 pniol/liter for cryopreserved and nonof hematopoietic stem cells and with defined, serum-free culcryopreserved cells from a cyclic neutropenia marrow speciture conditions will be required to further characterize the men-corresponding ED 50 's for 14-d CI-'U-GM growth were abnormal responses of myeloid progenitors to GM-CSF in 1.68 and 1.38 pmol/liter for the normal marrow cells and 8.32 cyclic neutropenia that are revealed when limiting concentraand 9.93 pmol/liter for the cyclic neutropenia marrow cells.
tions of this growth factor are examined in detail. Nonetheless, these studies provide an experimental basis for considering the use of exogenously administered recombinant myelopoietic Discussion growth factors to treat patients with childhood onset cyclic neutropenia, for such treatment might overcome or compenResults of these studies indicate that the numbers of myeloid sate for the disturbance of GM-CSF responsive myeloid proproccnitor cells (CFU-GM) recoverable from the marrow of genitor cell growth that is evident in this disease. 
